Your session is about to expire
← Back to Search
Dietary Supplement
Beet Juice Supplementation for Coronary Artery Disease
N/A
Recruiting
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline up to following 2 weeks of experimental condition
Summary
This trial looks at whether beet juice can help improve vascular and inspiratory muscle function in older adults with coronary artery disease.
Who is the study for?
This trial is for adults aged 60-85 with stable coronary artery disease (CAD), confirmed by an angiogram or history of heart issues, who are on optimal medical therapy. Participants must be non-smokers, not engaged in regular aerobic exercise, and women should be postmenopausal. Those with recent heart attacks, strokes, severe lung disease, uncontrolled high blood pressure or certain infections like hepatitis B/C and HIV cannot join.
What is being tested?
The study investigates the effects of beet juice supplementation on blood vessel and breathing muscle function in older adults with CAD. It compares two types of beetroot juice: one rich in nitrates and one depleted of nitrates to see which might improve these functions better.
What are the potential side effects?
While the trial does not specify side effects related to beet juice consumption directly, potential general side effects may include changes in bowel movements due to increased fiber intake from the juice and possible stomach discomfort.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline up to following 2 weeks of experimental condition
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline up to following 2 weeks of experimental condition
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in endothelial function
Change in inspiratory muscle function
Secondary study objectives
Change in central arterial hemodynamics
Arterial Stiffness
Change in functional capacity
+1 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: Nitrate rich beetroot juiceActive Control1 Intervention
Group II: Nitrate depleted beetroot juicePlacebo Group1 Intervention
Find a Location
Who is running the clinical trial?
University of FloridaLead Sponsor
1,401 Previous Clinical Trials
766,985 Total Patients Enrolled
45 Trials studying Coronary Artery Disease
30,174 Patients Enrolled for Coronary Artery Disease
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your heart's pumping ability is lower than 50%.You have unstable chest pain.You had a heart attack in the last 6 months.You have had a stroke in the past.You have a lung disease that makes it hard to breathe.You use any form of tobacco, including cigarettes or e-cigarettes.You regularly do aerobic exercise training.You have a history of heart disease based on a test showing more than half narrowing in a major heart blood vessel, a previous heart attack, or a past heart surgery to improve blood flow.You have stable coronary artery disease and are taking the right medications for it.You are between 60 and 85 years old.You have had heart surgery or procedures to open blocked arteries in the past 6 months.You have hepatitis B, hepatitis C, or HIV.You have ongoing or recurring seizures or other serious illnesses.You have had respiratory training in the past year or cardiac rehabilitation in the past 6 months.Your high blood pressure is not well controlled.
Research Study Groups:
This trial has the following groups:- Group 1: Nitrate rich beetroot juice
- Group 2: Nitrate depleted beetroot juice
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger